Integra Lifesciences Holdings Corp [NASDAQ: IART] plunged by -$5.75 during the normal trading session on while it closed the day at $23.14.
Integra Lifesciences Holdings Corp stock has also loss -20.86% of its value over the past 7 days. However, IART stock has declined by -41.42% in the 3 months of the year. Over the past six months meanwhile, it has lost -38.78% and lost -46.87% year-on date.
The market cap for IART stock reached $1.81 billion, with 78.17 million shares outstanding and 66.21 million shares in the current float. Compared to the average trading volume of 800.68K shares, IART reached a trading volume of 6166159 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Integra Lifesciences Holdings Corp [IART]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IART shares is $40.90 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IART stock is a recommendation set at 2.86. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Integra Lifesciences Holdings Corp shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 03, 2024. While these analysts kept the previous recommendation, Wells Fargo raised their target price from $40 to $49. The new note on the price target was released on December 05, 2023, representing the official price target for Integra Lifesciences Holdings Corp stock. Previously, the target price had yet another raise to $50, while CL King analysts kept a Buy rating on IART stock.
The Average True Range (ATR) for Integra Lifesciences Holdings Corp is set at 1.51, with the Price to Sales ratio for IART stock in the period of the last 12 months amounting to 1.17. The Price to Book ratio for the last quarter was 1.14, with the Price to Cash per share for the same quarter was set at 3.95. Price to Free Cash Flow for IART in the course of the last twelve months was 24.76 with Quick ratio for the last quarter at 2.18.
IART stock trade performance evaluation
Integra Lifesciences Holdings Corp [IART] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -20.86. With this latest performance, IART shares dropped by -31.94% in over the last four-week period, additionally sinking by -38.78% over the last 6 months – not to mention a drop of -53.90% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IART stock in for the last two-week period is set at 15.93, with the RSI for the last a single of trading hit 11.98, and the three-weeks RSI is set at 19.61 for Integra Lifesciences Holdings Corp [IART]. The present Moving Average for the last 50 days of trading for this stock 33.50, while it was recorded at 27.83 for the last single week of trading, and 39.14 for the last 200 days.
Integra Lifesciences Holdings Corp [IART]: An insightful look at the core fundamentals
Integra Lifesciences Holdings Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.18 and a Current Ratio set at 3.45.
Earnings per share (EPS) analysis for Integra Lifesciences Holdings Corp [IART] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IART. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Integra Lifesciences Holdings Corp go to 8.80%.
Integra Lifesciences Holdings Corp [IART]: Institutional Ownership
The top three institutional holders of IART stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in IART stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in IART stock with ownership which is approximately 5.8386%.
